38,6 %During periods of self-reported HIV risk, the difference in time covered by PrEP/PEP between the dynamic choice prevention and standard-of-care arms was 38.6%.
KenyaVIH/sidapublié 2024AIDS (London, England)PubMeddocument de 18 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
2 235 evidences · page 62 / 90
38,6 %During periods of self-reported HIV risk, the difference in time covered by PrEP/PEP between the dynamic choice prevention and standard-of-care arms was 38.6%.
KenyaVIH/sidapublié 2024AIDS (London, England)PubMeddocument de 18 observations
0,91 hazard_ratioThere was no difference in the hazard of healing between 108 HIV-positive and 108 age-matched HIV-negative men (HR 0.91, 95% CI 0.70–1.20).
KenyaVIH/sidapublié 2013PloS oneeurope_pmcdocument de 6 observations
3,66 USD_per_client_monthThe estimated economic cost per client-month on PEP was $3.66 USD for subsidized delivery.
KenyaVIH/sidapublié 2025BMC health services researchPubMeddocument de 13 observations
404 individualsThis study followed 404 HIV-positive women who contributed 2753 quarterly examination visits.
KenyaVIH/sidapublié 2017Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 5 observations
3,8 %Pre-acquisition CD8(+) T-cell responses were associated with enhanced post-acquisition HIV-specific CD8(+) T-cell proliferation of 3.8% compared to 1.0% (P=0.03).
KenyaVIH/sidapublié 2010AIDS (London, England)europe_pmcdocument de 2 observationsDOI 10.1097/qad.0b013e3283391d40
13,7 %Overall provider-initiated testing and counselling (PITC) coverage was 13.7% among adult outpatients aged 18–39 years at six health facilities in coastal Kenya.
KenyaVIH/sidapublié 2021PloS onePubMeddocument de 7 observations
34,54 USDThe average unit cost per male sex partner (MSP) traced was $34.54.
KenyaVIH/sidapublié 2022BMC health services researchPubMeddocument de 13 observations
1,8 per_100_person-yearsThe incidence rate difference was 1.8 per 100 person-years between the standard-of-care and intervention groups.
KenyaVIH/sidapublié 2024The lancet. HIVPubMeddocument de 9 observations
9,9 %Cumulative lost to follow-up incidence among children and adolescents initiating antiretroviral therapy in central Kenya was 9.9% at 12 months.
KenyaVIH/sidapublié 2022AIDS research and human retrovirusesPubMeddocument de 18 observations
94 %HIV self-testing acceptance was 94% in bars/clubs among adolescents and young adults in an urban settlement in Kenya.
KenyaVIH/sidapublié 2022AIDS and behaviorPubMeddocument de 3 observations
Among adolescent girls in Kenya, HIV testing increased between 2016/2017 and 2018.
KenyaVIH/sidaobservé 2016/2017, 2018publié 2022BMJ openPubMeddocument de 18 observations
994 womenOverall, 994 HIV-negative pregnant Kenyan women enrolled in the study.
KenyaVIH/sidaobservé November 2017 to June 2019publié 2024PloS onePubMeddocument de 5 observations
9 %Among females ineligible for assisted partner services (aPS), 9% had a previous HIV diagnosis.
KenyaVIH/sidaobservé May 2018 to August 2019publié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 12 observations
96 %HIV and malaria had the highest response rate (greater than 96%) and the broadest coverage in diagnostic capacity across facilities (greater than 76%).
Kenyapaludisme · VIH/sidaobservé 2018publié 2023BMC health services researchPubMeddocument de 7 observations
14,34 %HIV prevalence among long-distance truckers in the region is 14.34%.
KenyaVIH/sidapublié 2025Journal of the International Association of Providers of AIDS CarePubMed
43,9 %Among 911 women in the PrEP Implementation of Mothers in Antenatal Care trial in Kenya, 43.9% perceived themselves to be at high risk of HIV.
KenyaVIH/sidapublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 11 observations
92,5 %Among 4708 PLHIV initiated on IPT in Kenya between July 2015 and June 2018, 4356 (92.5%) had ever been screened for tuberculosis at every clinic visit.
Kenyatuberculose · VIH/sidaobservé July 2015 to June 2018publié 2020PloS onePubMeddocument de 8 observations
50 %In the absence of timely HIV testing and Antiretroviral Therapy (ART) initiation, more than half of infants living with HIV die before 2 years.
KenyaVIH/sidapublié 2020African Journal of Health SciencesOpenAlexdocument de 9 observations
6,9 %Overall pre-treatment HIV drug resistance increased from 6.9% before 2005 to 24.2% during 2016–2020 in Kenya.
KenyaVIH/sidaobservé before 2005publié 2024The Journal of antimicrobial chemotherapyPubMeddocument de 7 observations
3,1 per_100_person_yearsHIV incidence was 3.10 per 100 person-years in a higher-risk group of female sex workers in Mombasa, Kenya.
KenyaVIH/sidaobservé 2010 to 2017publié 2021AIDS and behavioreurope_pmcdocument de 4 observations
14 %In Kibera, 14% of people living with HIV reported missing medications at the onset of the COVID-19 pandemic.
KenyaVIH/sidapublié 2021International journal of environmental research and public healthPubMeddocument de 7 observations
16,9 %In the APS+HIVST arm, 16.9% (357/2111) of partners tested were newly diagnosed with HIV.
KenyaVIH/sidaobservé 2021publié 2024Journal of the International AIDS SocietyPubMeddocument de 15 observations
51 %Among the 705 HIV patients, 51% were married.
KenyaVIH/sidapublié 2023BioMed research internationalPubMeddocument de 6 observations
49 %Among HIV-positive children in Kenya, 49% were virally suppressed in 2018.
KenyaVIH/sidaobservé 2018publié 2022PloS onePubMeddocument de 10 observations
0,05 odds_ratioIntervention arm caregivers had less food insecurity than those in the control arm, with an odds ratio of 0.05 (95% CI 0.0047 to 0.54; p=0.014).
KenyaVIH/sidapublié 2026BMJ global healthPubMeddocument de 9 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.